SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

20 Jan 2022 Evaluate
With no major difference for the quarter endedDecember 2021 , the total revenue stood at Rs. 4730.00  millions.Net profit declined -22.73% to Rs. 255.00 millions from Rs. 330.00 millions.The Operating Profit of the company witnessed a decrease to 710.00 millions from 719.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 4730.00 4561.00 3.71 12205.00 15368.00 -20.58 20284.00 19884.00 2.01
Other Income 367.00 337.00 8.90 1264.00 1081.00 16.93 1502.00 2017.00 -25.53
PBIDT 710.00 719.00 -1.25 1610.00 3509.00 -54.12 4627.00 4877.00 -5.13
Interest 1.00 1.00 0.00 4.00 3.00 33.33 4.00 12.00 -66.67
PBDT 709.00 718.00 -1.25 1606.00 3506.00 -54.19 4623.00 6462.00 -28.46
Depreciation 276.00 260.00 6.15 801.00 781.00 2.56 1035.00 980.00 5.61
PBT 433.00 458.00 -5.46 805.00 2725.00 -70.46 3588.00 5482.00 -34.55
TAX 178.00 128.00 39.06 325.00 597.00 -45.56 783.00 1119.00 -30.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 255.00 330.00 -22.73 480.00 2128.00 -77.44 2805.00 4363.00 -35.71
Equity 6003.00 6000.00 0.05 6003.00 6000.00 0.05 6000.00 6000.00 0.00
PBIDTM(%) 15.01 15.76 -4.78 13.19 22.83 -42.23 22.81 24.53 -7.00

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×